Imaging striatal microglial activation in patients with Parkinson's disease

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Koshimori, Yuko ^a,b   Ko, Ji Hyun ^c   Mizrahi, Romina ^b   Rusjan, Pablo ^b   Mabrouk, Rostom ^b   Jacobs, Mark F ^b   Christopher, Leigh ^a,b   Hamani, Clement ^b   Lang, Anthony E ^b   Wilson, Alan A ^b   Houle, Sylvain ^b   Strafella, Antonio P ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL PROTEIN; FLUORINE 18; FLUORINE FEPPA F 18; TRANSLOCATOR PROTEIN 18; UNCLASSIFIED DRUG;

AGED; ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE; GENE INTERACTION; GENOTYPE; HUMAN; IN VIVO STUDY; MALE; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; TSPO GENE; CORPUS STRIATUM; DIAGNOSTIC IMAGING; GENETIC POLYMORPHISM; GENETICS; INFLAMMATION; METABOLISM; MIDDLE AGED; SCINTISCANNING;

AGED; CORPUS STRIATUM; FEMALE; GENOTYPE; HUMANS; INFLAMMATION; MALE; MICROGLIA; MIDDLE AGED; NEUROIMAGING; PARKINSON DISEASE; POLYMORPHISM, GENETIC; RADIONUCLIDE IMAGING;

EID: 84946544757     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138721     Document Type: Article

References (30)

1. McGeer PL, Itagaki MD, Boyes BE, McGeer EG. Reactive microglia are positiverfor HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 1988 Aug; 38(8):1285-91. PMID: 3399080
2. Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta Neuropathol. 2003 Dec; 106(6):518-26. PMID: 14513261
3. Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, et al. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett. 1994 Oct24; 180(2):147-50. PMID: 7700568
4. Dobbs RJ, Charlett A, Purkiss AG, Dobbs SM, Weller C, Peterson DW. Association of circulating TNF-alphaand IL-6 with ageing and parkinsonism. Acta Neurol Scand. 1999 Jul; 100(1):34-41. PMID: 10416510
5. Blum-Degen D, Muller T, Kuhn W, Gerlach M, Przuntek H, Riederer P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett. 1995 Dec29; 202(1-2):17-20. PMID: 8787820
6. Chen MK, Guilarte TR. Translocator protein 18 kDa(TSPO): molecular sensor of brain injury and repair. Pharmacol Ther. 2008 Apr; 118(1):1-17. doi: 10.1016/j.pharmthera.2007.12.004 PMID: 18374421
7. Venneti S, Lopresti BJ, Wiley CA. Molecular imaging of microglia/macrophages in the brain. Glia. 2013 Jan; 61(1):10-23. doi: 10.1002/glia.22357 PMID: 22615180
8. Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, et al. Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol. 2005 Feb; 57(2):168-75. PMID: 15668962
9. Kobylecki C, Counsell SJ, Cabanel N, Wachter T, Turkheimer FE, Eggert K, et al. Diffusion-weighted imaging and its relationship to microglial activation in parkinsonian syndromes. Parkinsonism Relat Disord. 2013 May; 19(5):527-32. doi: 10.1016/j.parkreldis.2013.01.017 PMID: 23425503
10. Wilson AA, Garcia A, Parkes J, McCormick P, Stephenson KA, Houle S, et al. Radiosynthesis and initial evaluation of [18F]-FEPPAfor PET imaging of peripheral benzodiazepine receptors. Nucl Med Biol. 2008 Apr; 35(3): 305-14. doi: 10.1016/j.nucmedbio.2007.12.009 PMID: 18355686
11. Rusjan PM, Wilson AA, Bloomfield PM, Vitcu I, Meyer JH, Houle S, et al. Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPAand positron emission tomography. J Cereb Blood FlowMetab. 2011 Aug; 31(8):1807-16. doi: 10.1038/jcbfm.2011.55 PMID: 21522163
12. Hatano K, Yamada T, Toyama H, Kudo G, Nomura M, Suzuki H, et al. Correlation between FEPPA uptake and microglia activation in 6-OHDA injured rat brain. NeuroImage. 2010; 52:S138.
13. Ko JH, Koshimori Y, Mizrahi R, Rusjan P, Wilson AA, Lang AE, et al. Voxel-based imaging of translocator protein 18 kDa (TSPO) in high-resolution PET. J Cereb Blood Flow Metab. 2013 Mar; 33(3):348-50. doi: 10.1038/jcbfm.2012.203 PMID: 23281426
14. Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G, et al. Role of translocator protein density, a maker of neuroinflammation in the brain during major depressive episodes. JAMA Psychiatry. 2015 Mar; 72(3):268-75. doi: 10.1001/jamapsychiatry.2014.2427 PMID: 25629589
15. Suridjan I, Pollock BG, Verhoeff NPLG, Voineskos AN, Chow T, Rusjan PM, et al. In-vivo imaging of grey and white matter neuroinflammation in Alzheimer's disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA. Mol Psychiatry. Forthcoming 2015.
16. Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood FlowMetab. 2012 Jan; 32(1):1-5. doi: 10.1038/jcbfm.2011.147 PMID: 22008728
17. Mizrahi R, Rusjan PM, Kennedy J, Pollock B, Mulsant B, Suridjan I, et al. Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA. J Cereb Blood Flow Metab. 2012 Jun; 32(6):968-72. doi: 10.1038/jcbfm.2012.46 PMID: 22472607
18. Rusjan P, Mamo D, Ginovart N, Hussey D, Vitcu I, Yasuno F, et al. An automated method for the extraction of regional data from PET images. Psychiatry Res. 2006 Jun 30; 147(1):79-89. PMID: 16797168
19. 11C]SL25.1188 in human brain with high-resolution positron emission tomography. J Cereb Blood FlowMetab. 2014; 34(5):883-9. doi: 10.1038/jcbfm.2014.34 PMID: 24517979
20. Bencherif B, Stumpf MJ, Links JM, Frost JJ. Application of MRI-based partial-volume correction to the analysis of PET images of mu-opioid receptors using statistical parametric mapping. J Nucl Med. 2004 Mar; 45(3):402-8. PMID: 15001679
21. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991 Oct 11; 19(19):5444. PMID: 1681511
22. Kreisl WC, Jenko KJ, Hines CS, Lyoo CH, Corona W, Morse CL, et al. A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. J Cereb Blood FlowMetab. 2013 Jan; 33(1):53-8. doi: 10. 1038/jcbfm.2012.131 PMID: 22968319
23. Varrone A, Oikonen V, Forsberg A, Joutsa J, Takano A, Solin O, et al. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [(18)F]FEMPA in Alzheimer's disease patients and control subjects. Eur J Nucl Med Mol Imaging. 2015 Mar; 42(3):438-46. doi: 10.1007/s00259-014-2955-8 PMID: 25412766
24. Narendran R, Lopresti BJ, Mason NS, Deuitch L, Paris J, Himes ML, et al. Cocaine abuse in humans is not associated with increased microglial activation: an 18-kDa translocator protein positron emission tomography imaging study with [11C]PBR28. J Neurosci. 2014 Jul 23; 34(30):9945-50. doi: 10.1523/JNEUROSCI.0928-14.2014 PMID: 25057196
25. Rone MB, Fan J, Papadopoulos V. Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states. Biochim Biophys Acta. 2009 Jul; 1791(7):646-58. doi: 10.1016/j.bbalip.2009.03.001 PMID: 19286473
26. Costa B, Pini S, Gabelloni P, Da Pozzo E, Abelli M, Lari L, et al. The spontaneous Ala147Thr amino acid substitution within the translocator protein influences pregnenolone production in lymphomono-cytes of healthy individuals. Endocrinology. 2009 Dec; 150(12):5438-45. doi: 10.1210/en.2009-0752 PMID: 19846611
27. Huang X, Alonso A, Guo X, Umbach DM, Lichtenstein ML, Ballantyne CM, et al. Stains, plasma, cholesterol, and risk of Parkinson's disease: a prospective study. Mov Disord. 2015 Apr; 30(4):552-9. doi: 10. 1002/mds.26152 PMID: 25639598
28. Streit WJ. Microglial response to brain injury: a brief synopsis. Toxicol Pathol. 2000 Jan-Feb; 28(1):28-30. PMID: 10668987
29. Choi HB, Khoo C, Ryu JK, van Breemen E, Kim SU, McLarnon JG. Inhibition of lipopolysaccharide-induced cyclooxygenase-2, tumor necrosis factor-alpha and [Ca2+]i responses in human microglia by the peripheral benzodiazepine receptor ligand PK11195. J Neurochem. 2002 Nov; 83(3):546-55. PMID: 12390516
30. Schumacher M, Akwa Y, Guennoun R, Robert F, Labombarda F, Desarnaud F, et al. Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J Neurocytol. 2000 May-Jun; 29 (5-6):307-26. PMID: 11424948